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Fomitopsis officinalis is a medicinal mushroom used in traditional European eighteenth and nineteenth 
century folk medicine. Fruiting bodies of F. officinalis were collected from the natural environment 
of Świętokrzyskie Province with the consent of the General Director for Environmental Protection 
in Warsaw. Mycelial cultures were obtained from fragments of F. officinalis fruiting bodies. The 
taxonomic position of the mushroom mycelium was confirmed using the PCR method. The presence 
of organic compounds was determined by HPLC–DAD analysis. Bioelements were determined 
by AF‑AAS. The biochemical composition of the tested mushroom material was confirmed with 
the FTIR method. Antioxidant properties were determined using the DPPH method, and the 
antiproliferative activity was assessed with the use of the MTT test. The presence of indole compounds 
(l‑tryptophan, 6‑methyl‑d,l‑tryptophan, melatonin, 5‑hydroxy‑l‑tryptophan), phenolic compounds 
(p‑hydroxybenzoic acid, gallic acid, catechin, phenylalanine), and sterols (ergosterol, ergosterol 
peroxide) as well as trace elements was confirmed in the mycelium and fruiting bodies of F. officinalis. 
Importantly, a high level of 5‑hydroxy‑l‑tryptophan in in vitro mycelium cultures (517.99 mg/100 g 
d.w) was recorded for the first time. The tested mushroom extracts also showed antioxidant and 
antiproliferative effects on the A549 lung cancer cell line, the DU145 prostate cancer cell line, and the 
A375 melanoma cell line.
Fomitopsis officinalis (Vill.) Bondartsev & Singer (quinine conk) is an arboreal mushroom species belonging to 
the Fomitopsidaceae family and Polyporales order. Given the rarity of its occurrence, it has been under strict 
species protection since 1983. It was also placed on “The IUCN Red List of Threatened Species” as a species at 
risk of extinction and included in the list of 33 endangered species in  Europe1.
The species is a parasite living on dead and alive coniferous tree trunks and causes intensive brown rot of 
wood. It can be found mostly on trees belonging to the Larix spp. and more seldom on trees of Abies spp., Pinus 
spp., Picea spp., Cydrus spp., Tsuga spp., and Pseudotsuga spp.2.
Due to its medicinal effects, F. officinalis was increasingly gaining popularity among eighteenth and nine-
teenth-century pharmacists, which led to a decline in its numbers in the natural habitat. Meanwhile, larch trees 
were exploited for their wood, resin, and tanbark, which further reduced the occurrence of F. officinalis and 
eventually contributed to its status of an endangered  species1.
Researchers consider F. officinalis as one of the medicinal mushroom species that was most commonly used 
in traditional European  medicine3. Fomitopsis officinalis was thought to be a unique panacea, which was effective 
in treatment of numerous ailments such as excessive sweating, dizziness, rheumatism, respiratory, digestive, and 
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excretory diseases,  cancer1,2, hemorrhoids, and dysmenorrhea and as an anti-inflammatory agent. In addition, 
the mushroom was believed to be a helminthagogue; furthermore, it was believed that large doses of this mush-
room would induce vomiting, while smaller ones acted as a diuretic. It also used to be one of the most important 
anti-inflammatory  agents4. In the second half of the nineteenth century and in the beginning of the twentieth 
century, it was mainly used to suppress night sweating in the course of several diseases, particularly in patients 
with tuberculosis. It was then progressively replaced with agaricin isolated from the mushroom itself. Indeed, 
modern studies on both crude extracts and compounds isolated from F. officinalis demonstrated a wide spectrum 
of therapeutic effects, including anti-inflammatory, cytotoxic, and antimicrobial  activity3,5.
To date, studies on F. officinalis have focused on the identification of polysaccharides and terpenoids in its 
fruiting bodies. However, there is still no extensive analysis of other biologically active compounds in both its 
mycelium and fruiting bodies.
Because of the endangered status of F. officinalis, the current study was performed on in vitro cultures of the 
species grown on a modified liquid medium according to Oddoux. The material was grown in shaken conditions 
and subsequently in aerial conditions for optimal growth. The taxonomic position of the fungus was confirmed 
using the PCR method. The study also characterized the biochemical composition of the tested mushroom 
material with the use of the FTIR method.
To confirm the therapeutic (antioxidant and antiproliferative) activity of F. officinalis, the content of indole, 
phenol, and sterol compounds in lyophilized extracts from mycelium and fruiting bodies was determined using 
reversed-phase high-performance liquid chromatography (RP-HPLC). Indole, phenol, and sterol compounds 
were analyzed both quantitatively and qualitatively. Furthermore, trace elements were verified by atomic absorp-
tion spectroscopy with flame atomization (F-AAS).
Antioxidant properties of extracts obtained from the species were determined using the DPPH method. The 
present study also aimed to investigate the antiproliferative activity of mycelium extracts and F. officinalis sporo-
carps against the A549 lung cancer cell line, the DU145 prostate cancer cell line, and the A375 melanoma cell line.
Results
The aerated conditions of the in vitro cultures contributed to a significant increase in F. officinalis biomass growth 
in the 10-L biofermenter; approximately 12 g dry weight (d.w.) of biomass per liter per day was obtained. This 
substantially exceeded the amount obtained in in vitro shaken cultures used  previously6. The resulting biomass 
from the aerated cultures was used for further genetic, biochemical, and biological research.
F. officinalis mycelium identification. A 599-bp PCR fragment of the internal transcribed spacer 
obtained using ITS1 and ITS4 specific primers was subjected to direct sequencing. Next, it was used to define 
the phylogenetic position of the tested mushroom. The sequence of this nucleotide fragment revealed over 99% 
similarity of JFo3619 to F. officinalis, as shown in the BLASTN program provided by NCBI. The MN534335 
GenBank accession number was granted to the analyzed nucleotide sequence. The N-J algorithm was applied 
to construct an evolutionary tree for F. officinalis JFo3619 and other closely related organisms belonging to the 
antrodia, i.e. the largest clade of brown rot fungi with ecological and biotechnological  importance7. The mush-
room was grouped together with other F. officinalis strains, thus creating a very well-determined cluster with a 
high bootstrap value (100%) (Fig. 1).
Biochemical characteristics of fruiting bodies and mycelium extracts. Protein, phenolic com‑
pounds, total carbohydrates, and proteolytic activity analyses. The analysis of the protein con-
tents in the fungal extracts showed that the highest amounts of this component in the fruiting bodies of F. 
officinalis (43.43  µg/mL). A higher concentration of phenolic compounds was noted in the fruiting bodies 
(0.061 mM) than in the mycelium obtained from the in vitro cultures (0.026 mM). A slightly higher level of total 
carbohydrates was detected in the mycelium biomass (24.8 µg/mL) (Table 1).
The proteolytic activity analysis showed effective digestion of the fluorogenic substrate at both pH tested 
(3.5 and 8.0) (Fig. 2).
The highest proteolytic activity was observed for the extracts of mycelium obtained from the in vitro culture 
at both pH levels (Fig. 2).
FTIR analysis. The spectra from the extracts of fruiting bodies and in vitro mycelial culture shared a high 
degree of similarity, with three strong bands in the 2960–2850 cm−1 range and a medium band in the 1470–
1430 cm−1 range, suggesting the presence of methylene bridges and/or methyl groups. The absorption at 1150–
1020 cm−1 may be attributed to various C–O bond vibrations and stretching. Combined with the strong –OH 
characteristic band peak at 3242 cm−1, this finding indicates the presence of polysaccharides, probably glucose 
derivatives such as  maltotriose12–14 (Fig. 3).
Qualitative and quantitative analysis of organic compounds and trace elements. Indole com-
pounds. The content of four indole compounds (5-hydroxy-l-tryptophan, l-tryptophan, 6-methyl-d,l-tryp-
tophan, and melatonin) was determined qualitatively and quantitatively. An example of a chromatogram of the 
RP-HPLC separation of indole compounds from F. officinalis mycelial cultures and fruiting bodies is shown in 
Fig. 4.
The highest content of 5-hydroxy-l-tryptophan (517.99 mg/100 g d.w.) was found in the mycelium extract. 
However, the compound was not found in the fruiting body extract.
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Figure 1.  Phylogenetic tree of F. officinalis JFo3619 and other closely related strains. The evolutionary history 
was inferred using the N-J  method8. The analysis involved 22 sequences. The percentages of replicate trees in 
which the associated taxa clustered together are indicated next to the  branches9. The evolutionary analyses were 
computed using the Jukes-Cantor  model10 and were conducted in MEGA7  software11.
Table 1.  Biochemical parameters of fruiting bodies and mycelium from in vitro cultures of F. officinalis 
extracts. 1 The concentration of proteins is expressed in µg/mL. 2 The content of phenolic compounds is 
expressed in mM. 3 The total carbohydrate level is expressed in µg/mL. 4 The antioxidative potential was 
expressed as percentage of inhibition of DPPH oxidation. All the results are the average of three replicates of 
three independent experiments. Pairs of means with different small letters are significantly different (p ≤ 0.05), 
n = 6; one-way analysis of variance (ANOVA) test was used.
Sample Proteins1 Phenolic  compounds2 Total  carbohydrates3 Antioxidative  properties4
Biochemical parameters
Fruiting bodies 43.43a ± 2.43 0.061a ± 0.005 23.4a ± 1.85 36.0% ± 5.6
Mycelium 33.86c ± 2.81 0.026c ± 0.005 24.8a ± 3.43 46.0% ± 1.8
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l-Tryptophan was found in both types of samples, and its content was 70.08 mg/100 g d.w. in the fruiting 
body extract and 8.06 mg/100 g d.w. in the mycelium extract. 6-Methyl-d,l-tryptophan and melatonin were also 
identified in samples from both the fruiting body and mycelium extracts.
The analysis of methanolic extracts confirmed a higher total content of indole compounds in mycelial cultures 
than in the fruiting bodies of this species. The content of indole compounds determined in the fruiting bodies 
and mycelia from the in vitro cultures is shown in Table 2.
Phenolic compounds. The presence of two of the 21 phenolic compound standards analyzed in the present 
study was confirmed (catechin, gallic acid). Additionally, an exogenous amino acid—phenylalanine was identi-
fied in the extract from the in vitro F. officinalis cultures (Fig. 5).
In the fruiting body extract, however, p-hydroxybenzoic acid was detected. Table 2 presents the content of 
phenolic compounds determined in the methanolic extracts of F. officinalis cultures.
Sterols. Sterol compounds such as ergosterol peroxide (in trace amounts) and ergosterol were identified in 
the analyzed extracts. Quantitative analysis, whose results are shown in Table 2, demonstrated high content of 
ergosterol in the mycelium extracts.
Trace elements. Table 2 shows the content of trace elements analyzed in the extracts of F. officinalis. The 
analysis showed that the mycelium and fruiting bodies of F. officinalis accumulated zinc, copper, iron, and mag-
nesium. The average zinc content in the mycelium from the in vitro cultures was 15.34 mg/100 g d.w., which was 
significantly higher than that in the fruiting bodies (9.62 mg/100 g d.w.).
The iron content was also three times higher in the mycelium (12.06 mg/100 g d.w.) than in the fruiting bodies 
(4.15 mg 100 g daily). The mycelium obtained from the mycelial cultures had increased content of magnesium 
ions, compared to that in the fruiting bodies, i.e. 218.9 mg/100 g d.w.
The accumulation of copper only was higher in the fruiting bodies of F. officinalis (3.22 mg/100 g d.w.) than 
in the mycelium from the in vitro cultures (0.72 mg/100 g d.w.).
Antioxidant activity. The assessment of the antioxidant capacity of the F. officinalis methanolic extract 
with the DPPH radical reduction method revealed that both the investigated mushroom samples could effec-
tively reduce DPPH radicals. The mycelium culture extract showed a higher antioxidant effect (46.4%) than the 
fruiting body extract (36.0%) (Table 1).
Antiproliferative activity. The extracts exerted different effects on cancer cell viability (Table 3). The most 
pronounced effect was shown by extracts obtained from the fruiting bodies.
The extract obtained from the fruiting bodies exhibited significant activity against two cancer cell lines 
(DU145 and A375), while no activity was found against the A549 cell line. In contrast, the extract of the F. 
Figure 2.  Level of proteolysis determined in acidic (pH 3.5) and alkaline conditions (pH 8.0) using the BSA 
fluorogenic substrate (EFB: extract of fruiting bodies, EMC: extract of mycelium from an in vitro culture). The 
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officinalis mycelium from the in vitro cultures not only maintained the anticancer activity of the polypore mush-
rooms but also exhibited activity against A549.
Discussion
The dynamics of F. officinalis mycelium growth differed from that reported in earlier studies, and the amount of 
the biomass obtained was higher than that noted  previously6.
Previously analyzed extracts from the fruiting bodies of the following fungal species: Agaricus bisporus, Armil-
laria mellea, Boletus edulis, Boletus badius, Cantharellus cibarius, Lactarius deliciosus, Lactarius deterrimus, Lec-
cinum rufum, Pleurotus ostreatus, Suillus luteus, and Tricholoma equestre were found to contain varying amounts 
of indole compounds ranging from 0.01 to 34.11 mg/100 g d.w.15. The amount of 5-hydroxy-L-tryptophan in the 
Figure 3.  FTIR-ATR spectra of (A) extract of fruiting bodies, (B) extract of mycelium from in vitro culture).
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extracts from the F. officinalis mycelium was, however, similar to that in the extracts of A. bisporus species, which 
were experimentally digested in an artificial digestive system (from 86.62 to 531 mg 100 g d.w.)6.
The total content of indole compounds in the mycelium extracts from the in vitro cultures was 526.39 mg/100 g 
d.w., while that in the extracts from the fruiting bodies was approximately 80.83 mg/100 g d.w.; this finding 
indicates that F. officinalis may be an important source of therapeutically and physiologically important indole 
 compounds16.
With their antioxidant properties and ability to protect cellular structures against oxidative damage, phenolic 
compounds are known for their biological  activities17. Gallic acid found in some species of higher fungi has been 
proven to have anti-inflammatory, antibacterial, antifungal, antiviral, and antioxidant  effects18–22. The authors 
systematically observed a correlation between the content of phenolic compounds and the antioxidant activity 
in mushroom species. Phenolic compounds are regarded as one of the most common antioxidants contained 
in food. Several scientific studies have confirmed the presence of phenolic acids and their derivatives in repre-
sentatives of Basidiomycota. Phenolic acids such as gallic, p-hydroxybenzoic, ferulic, protocatechic, p-coumaric, 
vanillic, and sinapic acids were found, among others, in many fungal species, e.g. A. mellea, B. badius, B. edulis, 
Figure 4.  (A) Example of a chromatogram of the analyzed indole compounds in Fomitopsis officinalis extract 
from mycelium and (B) from fruiting bodies.
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C. cibarius, L. deliciosus, and P. ostreatus6,23. p-Hydroxybenzoic, protocatechuic, and vanillic acid were detected in 
Fomitopsis pinicola fruiting  bodies24. Comparative analysis of Fomitopsis betulina fruiting bodies and mycelium 
showed the presence of syringic, gallic, 5-hydroxybenzoic, and 3,4-dihydrophenylacetic  acids17. In the present 
study, the content of phenolic compounds in the F. officinalis mycelium from the in vitro cultures was analyzed 
for the first time. The mycelium extracts showed a significant content of an exogenous amino acid—phenylala-
nine (34.6 mg/kg d.w.).
Table 2.  Content of selected organic compounds and bioelements in the extracts of fruiting bodies and 
mycelium of Fomitopsis officinalis (mg/100 g d.w.). n = 6; nd not detected. *Below the limit of detection; pairs of 
means with different small letters are significantly different (p ≤ 0.05); one-way analysis of variance (ANOVA) 
with a post hoc Tukey test was used.




l-tryptophan 70.08 ± 6.16a 8.06 ± 0.96a
6-Methyl-d,l-tryptophan 9.24 ± 1.34a,b 0.53 ± 0.06a,b
Melatonin 1.51 ± 0.52a,b 0.34 ± 0.03a,c
5-Hydroxy-l-tryptophan * 517.99 ± 5.29a,b,c
Phenolic compounds
p-Hydroxybenzoic acid 0.07 ± 0.00 *
Catechin nd 58.37 ± 0.9
Gallic acid nd 0.09 ± 0.0
Amino acid
Phenylalanine nd 346.48 ± 4.0
Sterols
Ergosterol 52.97 ± 0.21 102.02 ± 0.44
Ergosterol peroxide * *
Bioelements
Zn 9.62 ± 0.42a 15.34 ± 0.55a
Cu 3.22 ± 0.31a,b 0.72 ± 0.04a,b
Fe 4.15 ± 0.12a,c 12.06 ± 1.37a,c
Mg 189.5 ± 2.69a,b,c 218.9 ± 12.13a,b,c
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In representatives of Basidomycota, sterols are a common group of compounds, and ergosterol and ergosterol 
peroxide are the most representative among  them25. The results of a research study conducted at the University 
of Helsinki confirmed the content of these sterols in the range of 625–774 mg/100 g d.w.26.
Mushrooms are one of the few sources of ergosterol, which is the basic component of their cell membranes. 
It practically does not occur in the plant and animal kingdom. It is observed only in a few species of fish, and 
dairy products usually have to be enriched with vitamin D. Therefore, mushrooms are the main source of the 
compound. There are two active forms of vitamin D: vitamin  D2—ergocalciferol and  D3—cholecalciferol. Under 
the influence of UV radiation with a wavelength λ = 280–320, ergosterol is transformed into provitamin  D2, 
which converts to vitamin  D2 and ergosterol isomers: lumisterol and tachysterol. Subsequently, vitamin  D2 is 
metabolized to a biologically active form—1α, 25-dihydroxyvitamin  D2. The content of vitamin D in mushroom 
fruiting bodies depends on conditions prevailing in cultivation sites. Vitamin D increases the absorption of cal-
cium, a process that is particularly important during old age and childhood, because its deficiency may result in 
osteoporosis and rickets in children. In addition, recent studies have indicated that vitamin D reduces the risk 
of autoimmune and cardiovascular diseases and  malignancies25.
Several studies on the chemical composition of Basidiomycota representatives have shown high content of 
ergosterol in mushroom fruiting bodies. Many species of edible mushrooms are particularly widely studied in 
terms of this characteristic, including Cantharellus cibarius, in which the vitamin  D2 content of the dried fruiting 
body may reach 1.43 μg/g d.w after several  years27. Agaricus bisporus is another commonly studied species, as it is 
rich in this vitamin, with the average ergosterol content of up to 61.5 mg/100 g d.w. A high level of ergosterol has 
also been noted in the fruiting bodies of Boletus edulis and is estimated to be 500 mg/100 g d.w., while the vitamin 
 D2 content is 200 mg/100 g d.w. The Oriental black mushroom L. edodes (Shitake), which is used in the treatment 
of lifestyle diseases, contains approximately 85 mg ergosterol/100 g d.w.28. The ergosterol content measured in 
the mycelial cultures of F. officinalis (102.02 mg/100 g d.w.) was nearly twice that of its fruiting bodies (52.97 mg 
100 g d.w.). We obtained similar results in our previous studies, where we compared the content of ergosterol in 
the fruiting bodies and mycelium in Fomitopsis betulina, i.e. 103.99 and 41.29 mg/100 g DM.  respectively17. In 
turn, the ergosterol content in another species of the genus Fomitopsis, Fomitopsis pinicola, was 10,5 mg/100 g 
d.w. in fruiting  bodies29. Similar to ergosterol, ergosterol peroxide is a common sterol group compound in the 
Basidiomycota  cluster25. The steroid is characterized by a wide spectrum of biological  activity27. It exhibits anti-
inflammatory, antimicrobial, antioxidant, cytotoxic, and anticancer effects. The content of ergosterol peroxide 
depends, among others, on the concentration of reactive oxygen forms and the ratio between its synthesis and 
re-conversion to ergosterol. It is believed that the presence of antioxidant substances in biomass may affect the 
ratio of ergosterol to its peroxide  form25. The content of ergosterol peroxide in the fruiting bodies of B. edulis 
was 30 mg/100 g d.w.27. In the F. officinalis mycelial cultures, ergosterol peroxide was qualitatively determined 
in an amount below the limit of detection.
Mushrooms can accumulate larger amounts of trace elements in their fruiting bodies than herbaceous  plants30. 
The present results have demonstrated that in vitro culture of F. officinalis in aerated conditions yields mycelium 
with higher content of zinc, magnesium, and iron than fruiting bodies obtained from the natural environment.
Mushrooms from the Basidiomycota cluster are a relevant source of compounds with antioxidant properties, 
such as polyphenols, especially from the flavonoid class. In addition to their ability to capture free radicals and 
peroxide anions, they protect enzymes that offer antioxidant protection for the  body16,17,23. They prevent oxida-
tion of LDL fractions and atherosclerosis, simultaneously increasing the level of HDL  cholesterol16,17. Flavonoids 
have antimutagenic properties. Phenolic acids are another group of compounds with antioxidant  activity16,17. 
Since environmental factors stimulate the synthesis of free radicals, research is being conducted to identify new 
sources of antioxidants. Researchers are increasingly reporting the possibility of using macrofungi as a source 
of  antioxidants31.
Due to the presence of flavonoids and phenolic compounds with proven antioxidant activity in fruiting bod-
ies, F. officinalis is also considered a valuable source of compounds with antioxidant properties. Studies on the 
antioxidant capacity of methanolic extracts of F. officinalis confirmed this  activity32,33. The results of the current 
study provide additional evidence of the antioxidant activity of this species.
Florczak et al.31 conducted a study to assess the content of polyphenols and their antioxidant activity using 
the DPPH reagent in five species of multifocal fungi: P. ostreatus, Hirneola auricula, Flammulina velutipes, Poly-
porus squamosus, and Laetiporus sulphureus. The species were characterized by different contents of polyphe-
nolic compounds, which also depended on the type of extract: aqueous or ethanol. The strongest antioxidant 
capacity was found in both water and ethanol extracts of Polyporus squamosus, while the weakest capacity was 
noted for the ethanol extract of Hirneola auricula. The percentage inhibition of 4 mg/0.1  cm3 ethanol extract of 
P. squamosus was 25.36%, 8 mg/0.1  cm3 extract yielded 61.70% inhibition, and 12 mg/0.1  cm3 extract showed 
Table 3.  IC50 represents the ability of the fruiting bodies and mycelium from the in vitro cultures of Fomitopsis 
officinalis extracts to decrease the viability of DU 145, A549, and A375 cell lines after 48 h incubation, 
measured by the MTT assay.
Extract
IC50 (µg/mL)
DU 145 A549 A375
Fruiting bodies 11.08  > 100 12.51
Mycelium 10.04 22.58 50.55
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the highest inhibition of 92.55%. It is interesting to note that the content of polyphenolic compounds was not 
directly correlated with the antioxidant capacity of individual  species31. Research has also confirmed the signifi-
cant antioxidant activity of other species of the genus Fomitopsis: Fomitopsis pinicola and Fomitopsis betulina. The 
antioxidant activity determined with the FRAP method was 55.79 and 24.08 mmol trolox/kg d.w.,  respectively24. 
Given the results, it can be concluded that the methanol extracts obtained from F. officinalis showed antioxidant 
activity and can be a valuable source of antioxidant compounds.
In this work, the extracts were investigated for antiproliferative activity against three commonly studied cell 
 lines34–36. Previous studies showed that the cytotoxic properties of F. officinalis were mainly associated with the 
presence of lanostane  saponins37,38. The content of these compounds in mycelium and fruiting bodies may be 
responsible for the differences in the activity of extracts. These considerations require further studies, which 
would define the role of phytochemicals in the anticancer activity of in vitro cultured  mushrooms37,38.
In the current study, the content of bioactive substances and the antioxidant and antiproliferative properties of 
the arboreal medicinal mushroom F. officinalis were analyzed using the material obtained from in vitro cultures 
of fruiting bodies cultivated in shaken and aerated conditions.
The results indicate that F. officinalis may be a rich source of indole compounds that are important in both 
therapeutic and physiological processes. To the best of our knowledge, the presence of 5-hydroxy-l-tryptophan, 
l-tryptophan, 6-methyl-d,l-tryptophan, and melatonin has been determined both quantitatively and qualita-
tively for the first time in this species. A surprising and important finding is the particularly high content of 
5-hydroxy-l-tryptophan in the mycelium from the in vitro cultures of F. officinalis. Furthermore, the phenolic, 
indole, and sterol compounds as well as trace elements found in the extracts of the F. officinalis mycelium and 
fruiting bodies may contribute to the antioxidant and antiproliferative effects.
The results of this research study, especially the FTIR analyses, showed several similarities in the composition 
of both extracts; this implies that not only fruiting bodies but also mycelia obtained from in vitro cultures can 
synthesize metabolites with potential medicinal, pharmaceutical, and cosmetological use. Further experiments 
should involve testing the antitumor effects of F. officinalis extracts in animal models.
Methods
Mushroom material. Fruiting bodies were collected from the natural environment in Świętokrzyskie Prov-
ince (Poland) with the consent of the General Director for Environmental Protection in Warsaw. The mush-
rooms were identified by Jacek Piętka (Department of Forest Protection, Institute of Forest Sciences, Warsaw 
University of Life Sciences—SGGW).
Mycelial cultures were obtained from fragments of fruiting bodies placed on Petri dishes with solid agar 
growth medium. After 4 weeks, the in vitro cultures were passaged to 250 mL of liquid medium according 
to Oddoux. The laboratory conditions were identical to those in the natural environment in vitro: a 16:8-h 
light–dark cycle (lighting: 900 lx), temperature: 25 ± 2 °C. The material immersed in liquid medium was shaken 
at 140 rpm for 4 weeks using an rotary shaker (Altel, Poland).
Subsequently, the mycelium from the in vitro cultures was transferred from Erlenmeyer flasks to an in-house 
designed 10-L biofermentor and was kept in aerated conditions (sterile air and discharged  CO2) for further 
optimal growth. After 10 days, the biomass was separated from the substrate and rinsed four times with distilled 
water. The biomass was then frozen and lyophilized.
PCR amplification and sequencing of the mushroom ITS region. Fourteen-day-old mycelia were 
transferred into a sterile 2.0 mL Lysing Matrix A tube (MP Biomedicals, USA) and homogenized in a Fast-
Prep-24 Homogenizer (MP Biomedicals, USA) in 0.5 mL of spermidine-SDS buffer for 3 × 20 s at 5 m/s rotor 
speed. After centrifugation (10,000×g, 4  °C, 10  min), the supernatant was used for further DNA extraction 
according to the method of Borges et al.39. The quantity and purity of the DNA were evaluated using an ND-1000 
spectrophotometer (Thermo Scientific, USA). To confirm the genetic identity of the fungus, the ribosomal RNA 
gene fragment was amplified using the universal primers ITS1 (TCC GTA GGT GAA CCT GCG G) and ITS4 (TCC 
TCC GCT TAT TGA TAT GC) as described by White et al.40. PCR was performed in a T-Personal thermal cycler 
(Biometra, Germany) using DreamTaq Green PCR Master Mix (Thermo Scientific, USA). The amplified region 
was analyzed by direct sequencing of the PCR product. Automatic sequencing was performed using the BigDye 
Terminator Cycle Sequencing Kit and ABI PRISM 310/3730 XL sequencers (Applied Biosystems, USA). Data 
from ITS sequencing were analyzed with ChromasPro v.1.6 software (Technelysium Pty Ltd, Australia). Data-
base search was performed with the BLAST program at the National Center for Biotechnology Information 
(Bethesda, MD, USA)41. Multiple DNA sequence alignments were performed with the Clustal-W  algorithm42. 
The neighbor-joining (NJ) algorithm was used to construct a phylogenetic tree as implemented in MEGA v.7.0 
 software11. The topology of the tree was evaluated by bootstrap analysis of the sequence data based on 1000 
random resampling.
Biochemical analysis. Sample preparation. Biochemical analyses were carried out on two types of mush-
room extracts: methanol extract of F. officinalis fruiting bodies obtained from the natural environment and 
methanol extract of biomass produced in in vitro conditions. Lyophilized preparations were dissolved at the 
ratio of 1 mg of lyophilizate/1 mL of methanol. The samples of the biological material were used in all the bio-
chemical analyses.
Determination of the concentration of protein and phenolic compounds (PC), total carbohydrate (TC) level, and 
proteolytic activity. The protein concentration in the samples was determined using Coomassie brilliant blue 
(G-250) dye with bovine serum albumin as a standard. The concentration of proteins was expressed in µg/
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mL43. The PC concentration was determined with the DASA test using diazosulfanilamide (SA) as a reaction 
 substrate44. The absorbances obtained were recorded at 500 nm at room temperature and compared with the data 
from the calibration curve (y = 6.85x − 0.0218,  R2 = 0.999). The TC content in the samples was determined with 
the phenol–sulfuric acid-based method. D-glucose served as a standard substrate for the calibration curve, and 
the results were expressed in µg/mL45. The proteolytic activity of the samples was estimated using the fluorescent 
micro-method with BSA-BIODYPY heavily labeled bovine serum albumin (Invitrogen DQ Red BSA, Thermo 
Scientific, USA) as a reaction substrate. The analysis was conducted at two different pH values (3.5 and 8.0). The 
reaction mixture contained 50 µL (50 µg/mL) of the reaction substrate, 50 µL (1 mg/mL) of the sample, and 100 
µL of McIlvaine buffer (pH 3.5 or 8.0). The kinetic substrate digestion was determined for 30 min (excitation 
590 nm and emission 620 nm) using a Tecan Infinite m200 plate reader. The specific activity of proteases was 
calculated based on the fluorescence increase corresponding to the substrate digestion rate and expressed in 
relative fluorescence units (U) per minute per µg of protein.
FTIR analysis. Fourier-transform infrared spectroscopy of the methanol extracts of the fruiting bodies and 
biomass of F. officinalis produced in in vitro conditions was performed using a Nicolet 8700 A spectrometer 
(Thermo Scientific, USA) equipped with an FT Raman Nicolet NXR module in the 4000–400 cm−1 wavelength 
range.
Determination of indole and phenolic compound. The lyophilized biomass (5 g) was extracted five times with 
100 mL of methanol using ultrasound at a frequency of 49 kHz for 30 min (Sonic-2, Polsonic, Poland). Qualita-
tive and quantitative HPLC–DAD analyses were performed according to previously published protocols: indole 
 compounds6,17 and phenolic  compounds17.
Determination of sterols. The lyophilized biomass (5  g) was extracted with a mixture of methanol/dichlo-
romethane 75:25 (v/v). The mixture was sonicated at 40 kHz for 10 min. After 2 h, the extract was centrifuged at 
12,000 rpm for 5 min and decanted. Qualitative and quantitative HPLC–DAD analyses were performed accord-
ing to the previously published  protocols17.
Determination of trace elements. The lyophilized mushroom materials were weighed in amounts of 0.2 g each 
with an accuracy of 0.01 g. After weighing, the material was transferred to Teflon vessels, to which 5 mL of con-
centrated 65%  HNO3 (Merck, Germany) and 2 mL of 30%  H2O2 (Merck, Germany) were added. Mineralization 
was conducted in the Magnum II microwave apparatus (Ertec, Poland) in three stages (10 min each), with 100% 
power. The temperature of the device was maintained at 295 °C. After the mineralization process, the solutions 
were transferred to quartz evaporators using water distilled four times. The residue of the reagents and water 
was evaporated on a heating plate at 150 °C. The residue of the mineralized sample obtained after evaporation 
was quantitatively transferred to 10-mL volumetric flasks with water distilled four times. The samples prepared 
in this way were analyzed with the use of Flame Atomic Absorption Spectrometry (F-AAS). Mg, Zn, Cu, and Fe 
were analyzed using an iCE3300 Thermo Scientific spectrophotometer (USA). Standard curves were prepared 
for each of the tested bioelements using various concentrations of the standards (Merck, Germany). The miner-
alization process and F-AAS analysis were conducted following the previously published  methods46.
Antioxidant activity. The DPPH method performed according to the procedure proposed by Paduch et al.47 
was used to determine the antioxidative properties of all mushroom samples. The procedure was also described 
in detail by Jaszek et al.48 and Matuszewska et al.49.
Antiproliferative activity determination. Cell cultures. The A549 (ATCC) lung cancer cell line, the 
DU145 (ATCC) prostate cancer cell line, and the A375 (ATCC) melanoma cell line were used. Cells were grown 
in culture flasks in standard conditions of temperature (37 °C) and  CO2 concentration (5%). The A549 and A375 
cell lines were cultured in DMEM medium (Gibco) supplemented with 10% fetal bovine serum (FBS) (Gibco, 
Ireland) and antibiotics (Lonza, Switzerland), while the DU145 cells were cultured in DMEM-F12 medium 
(Gibco, Ireland) supplemented with 10% FBS and antibiotics. Doxorubicin hydrochloride (> 95% purity) was 
purchased from Enzo Life Sciences, USA.
Cell viability. Cells were seeded on 96-multiwell plates at the density of 5000 cells/well. After 24 h, the cells 
were incubated with extracts dissolved in DMSO to a final concentration of 0–100 µg/mL, and the plates were 
gently mixed. Negative (vehicle) and positive (doxorubicin hydrochloride) controls were included. After 48 h 
incubation, the MTT solution (5 mg/mL) was added to the medium. After 3 h, when black crystals of formazan 
appeared at the bottom of the wells, the medium was removed and formazan was dissolved in DMSO. Absorb-
ance was read on a multiwell reader (Spectra Max iD3, Molecular Devices, USA) at 570 nm. Cell viability was 
determined by dividing the absorbance of the experimental wells by the absorbance of the control wells (× 100%). 
Three separate repeats of the experiment were performed. DMSO had no significant effect on cell viability.  IC50 
was calculated using GraphPad Prism 7.0150.
Statistical analysis. One-way analysis of variance (ANOVA) with a post hoc Tukey test was used to validate the 
statistical hypotheses at p = 0.05 for all tests. All statistical analyses were performed using the Statistica software.
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